Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-Hodgkin's lymphoma

M R Smith1

  • 1Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

Current Problems in Cancer
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Non-Hodgkin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pollinators support the nutrition and income of vulnerable communities.

Nature·2026
Same author

Correction to: MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies.

Cell death & disease·2024
Same author

Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Potential rise in iron deficiency due to future anthropogenic carbon dioxide emissions.

GeoHealth·2020
Same author

Global Health Implications of Nutrient Changes in Rice Under High Atmospheric Carbon Dioxide.

GeoHealth·2020
Same author

Bacterial community structure and response to nitrogen amendments in Lake Shenandoah (VA, USA).

Water science and technology : a journal of the International Association on Water Pollution Research·2019
Same journal

Clinical impact of a single time-point protocol paired FDG-PET and radioactive iodine scan for comprehensive disease assessment in differentiated thyroid cancer.

Current problems in cancer·2026
Same journal

Patterns of care for older multiple myeloma patients in the U.S.: An analysis of the national cancer database.

Current problems in cancer·2026
Same journal

Too late to fall: Time to PSA nadir and early oncologic failure after cryotherapy and high-intensity focused ultrasound for localized prostate cancer.

Current problems in cancer·2026
Same journal

Artificial intelligence, omics, and biomarkers: Redefining lung cancer early detection.

Current problems in cancer·2026
Same journal

Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma.

Current problems in cancer·2026
Same journal

Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer.

Current problems in cancer·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Non-Hodgkin's lymphomas (NHLs) are a diverse group of cancers affecting the lymphatic system.
  • NHLs represent a significant public health concern, ranking as the sixth most common cancer and cause of cancer-related deaths in the U.S.
  • The incidence of NHLs has increased over the past four decades, with a complex interplay of factors contributing to this rise.

Purpose of the Study:

  • To provide a comprehensive review of non-Hodgkin's lymphomas.
  • To discuss the classification, pathology, and clinical relevance of NHL subtypes.
  • To explore current and emerging treatment strategies for various NHLs.

Main Methods:

  • Review of existing literature on lymphoid neoplasia and non-Hodgkin's lymphomas.

Related Experiment Videos

  • Analysis of histopathology, cellular, and molecular techniques in lymphoma classification.
  • Examination of clinical outcomes and treatment efficacy based on prognostic factors.

    • Main Results:

    • NHLs are classified based on their correlation with normal lymphoid development stages.
    • Histology, immunohistochemistry, and molecular studies are crucial for subtype determination.
    • Low-grade lymphomas are often incurable, requiring palliative care, while intermediate and high-grade lymphomas are potentially curable with chemotherapy.

    Conclusions:

    • Understanding lymphoid development aids in classifying and treating NHLs.
    • Aggressive chemotherapy, such as CHOP, offers potential cures for intermediate and high-grade lymphomas.
    • Ongoing research focuses on novel therapies, including stem cell support and biologic agents, for refractory cases and special patient populations.